Pharmacotherapy for co-occurring alcohol and drug disorders in schizophrenia and bipolar disorder: Where is the evidence?

Acta Neuropsychiatrica

Volumn 22, Issue 2, 2010, Pages 95-97

  Lubman, Dan I ^a   Berk, Michael ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DISULFIRAM; FLUPENTIXOL DECANOATE; LITHIUM; NALTREXONE; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZUCLOPENTHIXOL;

ALCOHOLISM; BIPOLAR DISORDER; COGNITIVE THERAPY; DETOXIFICATION; DRUG DEPENDENCE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FOLLOW UP; HUMAN; LONG TERM CARE; MENTAL DISEASE; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SHORT SURVEY; SOCIAL ADAPTATION; SUBSTANCE ABUSE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 77949415696     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2010.00446.x     Document Type: Short Survey

References (14)

1. REGIER DA, FARMER ME, RAE DS et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA 1990;264:2511-2518.
2. LUBMAN DI, SUNDRAM S. Substance misuse in patients with schizophrenia: a primary care guide. Med J Aust 2003;178:S71-S75.
3. GREEN AI, NOORDSY DL, BRUNETTE MF, O'KEEFE C. Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat 2008;34:61-71.
4. LAMBERT M, CONUS P, LUBMAN DI et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005;112:141-148.
5. KEMP DE, GAO K, GANOCY SJ, ELHAJ O, BILALI SR, CONROY C, FINDLING RL, CALABRESE JR. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry 2009;70:113-121.
6. MATHIAS S, LUBMAN DI, HIDES L. Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry 2008;69:358-367.
7. SAN L, ARRANZ B, MARTINEZ-RAGA J. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders. Eur Addict Res 2007;13:230-243.
8. BAKER A, HIDES L, LUBMAN DI. Treatment of cannabis use among people with psychotic and depressive disorders: a systematic review. J Clin Psychiatry 2010 (in press).
9. RUBIO G, MARTINEZ I, PONCE G, JIMENEZ-ARRIERO MA, LOPEZ-MUNOZ F, ALAMO C. Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity. Can J Psychiatry 2006;51:531-539.
10. BROWN ES, GARZA M, CARMODY TJ. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 2008;69:701-705.
11. NEJTEK VA, AVILA M, CHEN LA et al. Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry 2008;69:1257-1266.
12. SALLOUM IM, CORNELIUS JR, DALEY DC, KIRISCI L, HIMMELHOCH JM, THASE ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005;62:37-45.
13. PETRAKIS IL, NICH C, RALEVSKI E. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophr Bull 2006;32:644-54.
14. DRAKE RE, O'NEAL EL, WALLACH MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008;34:123-138.